Case No. | Age (yrs) | Sex | Risk Factors | Valve | Surgery (y/n) | Antibiotic Regimen | Duration | Survived(y/n) | Ref No. |
---|---|---|---|---|---|---|---|---|---|
1 | 69 | M | Cystoscopy | Av | N | β Lactam/AG | 6wks | Y | [13] |
2 | 54 | M | Phimosis | Mv | Y | β Lactam | 6wks | Y | [32] |
3 | 43 | M | Hepatitis C | Av | N | β Lactam/AG | 5 days | N | [19] |
4 | 68 | M | Indwelling Catheter | Av | Y | β Lactam/AG | 6/2wks | Y | [29] |
5 | 80 | M | Malignancy | Av | Y | β Lactam | 6wks | Y | [33] |
6 | 77 | M | BPH | Av | N | β Lactam/Van | – | N | [10] |
7 | 68 | M | BPH | Mv | N |
β Lactam/AG; oral regimen | 3wks; unknown | Y | [14] |
8 | 75 | M | Cystoscopy | Av | Y | β Lactam/AG | 6wks | Y | [15] |
9 | 89 | M | TURP | Mv | N | β Lactam/AG | 7 days | N | [16] |
10 | 81 | M | UTI | Av | N | β Lactam/AG | 2wks/8da | N | [34] |
11 | 42 | M | None | Av | Y | β Lactam/AG | 6wks | Y | [18] |
12 | 49 | M | – | Av | – | β Lactam/AG | – | Y | [35] |
13 | 54 | M | Urethral Stricture | T/Av | N | β Lactam/AG | – | N | [36] |
14 | 69 | M | Malignancy | Av | Y | β Lactam | 12wks | Y | [17] |
15 | 62 | M | BPH | M/Av | Y | β Lactam/Rif, AG | 6wks, AG 2wks | Y | [25] |
16 | 78 | M | Aortic stenosis | Av | N | β Lactam/AG | 10 days | N | [26] |
17 | 74 | M | BPH | Mv | Y | β Lactam/AG | 4wks | N | [11] |
18 | 81 | M | BPH | Mv | N | β Lactam/AG | 6wks | Y | [12] |
19 | 78 | M | Indwelling Catheter | Av | N | β Lactam | – | N | [12] |
20 | 87 | M | BPH | Mv | N | – | – | N | [12] |
21 | 78 | F | Ureteral Stent | Av | N | β Lactam/Van | 2wks | N | [12] |
22 | 48 | M | ASD | Mv | N | β Lactam/AG | – | Y | [27] |
23 | 79 | F | UTI | Av | N | β Lactam | 6wks | Y | [27] |
24 | 91 | M | Indwelling Catheter | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
25 | 91 | M | BPH | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
26 | 89 | F | – | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
27 | 86 | M | Urethral Stricture | Av | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
28 | 83 | M | Urethral Stricture | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
29 | 80 | F | – | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
30 | 77 | M | – | Av | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
31 | 75 | M | BPH | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
32 | 74 | M | Suprapubic Catheter | – | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
33 | 65 | M | Indwelling Catheter | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
34 | 53 | M | Dysuria | Av | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
35 | 49 | F | Intermittent Catheter | Av | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
36 | 81 | M | Indwelling Catheter | Mv | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
37 | 74 | F | Malignancy | – | – | β Lactam/AG | 4wks/10d^{b} | Y | [5] |
38 | 87 | M | Malignancy | Mv | – | β Lactam/AG | – | N | [9] |
39 | 77 | M | Liver Failure | Av | – | β Lactam/AG | – | Y | [9] |
40 | 83 | M | Indwelling Catheter | Mv | – | β Lactam/AG | – | Y | [9] |
41 | 73 | M | Suprapubic Catheter | – | – | β Lactam/AG | – | N | [9] |
42 | 88 | F | Aortic Stenosis | Av | – | β Lactam/AG | – | Y | [9] |
43 | 43 | M | Indwelling Catheter | Mv | Y | β Lactam/AG | 6wks | Y | ^{a} |